Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mazumdar

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Cancer|May 15, 1994
Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapyB A Murphy, R J Motzer, M Mazumdar, et al.
Investigational New Drugs|August 25, 2000
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, M Mazumdar, et al.
British Journal of Anaesthesia|December 24, 2018
Non-opioid analgesic modes of pain management are associated with reduced postoperative complications and resource utilisation: a retrospective study of obstructive sleep apnoea patients undergoing elective joint arthroplastyC Cozowicz, J Poeran, N Zubizarreta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcomaS R Grobmyer, R G Maki, G D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancerR J Motzer, J Sheinfeld, M Mazumdar, et al.
Journal of the National Cancer Institute|November 17, 1993
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsR J Motzer, M Mazumdar, S C Gulati, et al.
Blood|February 1, 1997
Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expressionR Gorlick, E Goker, T Trippett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinumJ Vuky, M Bains, J Bacik, et al.
Annals of Surgical Oncology|February 24, 2001
Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 proceduresH S Cody, J Fey, T Akhurst, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Cancer|May 15, 1994
Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapyB A Murphy, R J Motzer, M Mazumdar, et al.
Investigational New Drugs|August 25, 2000
Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, M Mazumdar, et al.
British Journal of Anaesthesia|December 24, 2018
Non-opioid analgesic modes of pain management are associated with reduced postoperative complications and resource utilisation: a retrospective study of obstructive sleep apnoea patients undergoing elective joint arthroplastyC Cozowicz, J Poeran, N Zubizarreta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcomaS R Grobmyer, R G Maki, G D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancerR J Motzer, J Sheinfeld, M Mazumdar, et al.
Journal of the National Cancer Institute|November 17, 1993
Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsR J Motzer, M Mazumdar, S C Gulati, et al.
Blood|February 1, 1997
Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expressionR Gorlick, E Goker, T Trippett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2001
Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinumJ Vuky, M Bains, J Bacik, et al.
Annals of Surgical Oncology|February 24, 2001
Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 proceduresH S Cody, J Fey, T Akhurst, et al.
Pageof 11